Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 Am J Surg
1 Ann Oncol
1 Ann Surg Oncol
7 BMC Cancer
1 Br J Cancer
3 Breast Cancer
1 Breast Cancer Res
3 Breast Cancer Res Treat
2 Breast J
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
1 Cancer Res
4 Clin Breast Cancer
1 Clin Exp Metastasis
2 Eur J Surg Oncol
1 Exp Cell Res
1 Gene
1 Histopathology
2 Int J Cancer
2 Int J Oncol
1 J Biol Chem
1 J Clin Invest
3 N Engl J Med
1 NPJ Breast Cancer
5 Oncol Rep
7 PLoS One

    Am J Surg

  1. TSUNG K, Grobmyer SR, Tu C, Abraham J, et al
    Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2017 Nov 14. pii: S0002-9610(17)30998.
    >> Share

    Ann Oncol

  2. PALUCH-SHIMON S, Peccatori FA
    BRCA 1 and 2 mutation status: the elephant in the room during oncofertility counseling for young breast cancer patients.
    Ann Oncol. 2017 Dec 5. pii: 4693825. doi: 10.1093.
    >> Share

    Ann Surg Oncol

  3. SISO C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, et al
    Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
    Ann Surg Oncol. 2017 Dec 1. pii: 10.1245/s10434-017-6270.
    >> Share

    BMC Cancer

  4. OCHNIK AM, Baxter RC
    Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer.
    BMC Cancer. 2017;17:820.
    >> Share

  5. THOMAS ET, Del Mar C, Glasziou P, Wright G, et al
    Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.
    BMC Cancer. 2017;17:808.
    >> Share

  6. HE D, Fang Y, Gunter MJ, Xu D, et al
    Incidence of breast cancer in Chinese women exposed to the 1959-1961 great Chinese famine.
    BMC Cancer. 2017;17:824.
    >> Share

  7. IIZUMI S, Shimoi T, Tsushita N, Bun S, et al
    Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.
    BMC Cancer. 2017;17:819.
    >> Share

  8. BAXTER GD, Liu L, Petrich S, Gisselman AS, et al
    Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.
    BMC Cancer. 2017;17:833.
    >> Share

  9. PHAM TND, Perez White BE, Zhao H, Mortazavi F, et al
    Protein kinase C alpha enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin.
    BMC Cancer. 2017;17:832.
    >> Share

  10. KO H, Shin J, Lee JE, Nam SJ, et al
    Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    BMC Cancer. 2017;17:821.
    >> Share


    Breast cancer screening.
    BMJ. 2017;359:j5625.
    >> Share

    Br J Cancer

  12. NANDY SB, Orozco A, Lopez-Valdez R, Roberts R, et al
    Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis.
    Br J Cancer. 2017;117:1665-1675.
    >> Share

    Breast Cancer

  13. TSUDA B, Miyamoto A, Yokoyama K, Ogiya R, et al
    B-cell populations are expanded in breast cancer patients compared with healthy controls.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0824.
    >> Share

  14. DORFEL S, Steffens CC, Meyer D, Tesch H, et al
    Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0823.
    >> Share

  15. HE J, Chen Y, Cai L, Li Z, et al
    UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.
    Breast Cancer. 2017 Dec 1. pii: 10.1007/s12282-017-0820.
    >> Share

    Breast Cancer Res

  16. YU J, Qin B, Moyer AM, Sinnwell JP, et al
    Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
    Breast Cancer Res. 2017;19:130.
    >> Share

    Breast Cancer Res Treat

  17. PISTILLI B, Pluard T, Urruticoechea A, Farci D, et al
    Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy.
    Breast Cancer Res Treat. 2017 Dec 2. pii: 10.1007/s10549-017-4596.
    >> Share

  18. IBRAHIM MFK, Hilton J, Mazzarello S, Fergusson D, et al
    A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
    Breast Cancer Res Treat. 2017 Dec 6. pii: 10.1007/s10549-017-4604.
    >> Share

  19. WANG J, Fan T, He Y, Chen X, et al
    (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
    Breast Cancer Res Treat. 2017 Dec 6. pii: 10.1007/s10549-017-4591.
    >> Share

    Breast J

  20. BAYO J, Avino V, Toscano F, Jimenez F, et al
    Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12927.
    >> Share

  21. KUMAR RV, Bhasker S
    A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.
    Breast J. 2017 Dec 5. doi: 10.1111/tbj.12965.
    >> Share


  22. MILLER JW, Smith JL, Ryerson AB, Tucker TC, et al
    Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5100-5118.
    >> Share

    Cancer Chemother Pharmacol

  23. SHIEN T, Doihara H, Sato N, Anan K, et al
    Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.
    Cancer Chemother Pharmacol. 2017 Dec 1. pii: 10.1007/s00280-017-3491.
    >> Share

    Cancer Lett

  24. KIM HY, Ha Thi HT, Hong S
    IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor.
    Cancer Lett. 2017;415:30-39.
    >> Share

    Cancer Res

  25. WU Y, Zhang Z, Cenciarini ME, Proietti CJ, et al
    Tamoxifen resistance in breast cancer is regulated by the EZH2-ERalpha-GREB1 transcriptional axis.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1327.
    >> Share

    Clin Breast Cancer

  26. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    >> Share

  27. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    >> Share

  28. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    >> Share

  29. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    >> Share

    Clin Exp Metastasis

  30. SOON PS, Provan PJ, Kim E, Pathmanathan N, et al
    Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Clin Exp Metastasis. 2017 Dec 6. pii: 10.1007/s10585-017-9868.
    >> Share

    Eur J Surg Oncol

  31. KRISCHER B, Forte S, Niemann T, Kubik-Huch RA, et al
    Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Eur J Surg Oncol. 2017 Nov 26. pii: S0748-7983(17)30978.
    >> Share

  32. WESTENEND PJ, Storm R, Kock M, Kitzen J, et al
    The role of ultrasonography of the axilla and fine-needle aspiration cytology in breast cancer patients in the era of neo-adjuvant chemotherapy and axillary radiation; prevention of futile sentinel node procedures revisited.
    Eur J Surg Oncol. 2017 Nov 29. pii: S0748-7983(17)30979.
    >> Share

    Exp Cell Res

  33. GONG XF, Yu AL, Tang J, Wang CL, et al
    MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30640.
    >> Share


  34. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    >> Share


  35. STALHAMMAR G, Robertson S, Wedlund L, Lippert M, et al
    Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
    Histopathology. 2017 Dec 8. doi: 10.1111/his.13452.
    >> Share

    Int J Cancer

  36. DALLASPEZIA S, Cantamessa S, Benedetti F
    Light Therapy and Mood in Breast Cancer.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31188.
    >> Share

  37. MCKENZIE F, Zietsman A, Galukande M, Anele A, et al
    Drivers of advanced stage at breast cancer diagnosis in the multi-country African Breast Cancer - Disparities in Outcomes (ABC-DO) study.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31187.
    >> Share

    Int J Oncol

  38. ALONSO-GONZALEZ C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, et al
    Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells.
    Int J Oncol. 2017 Nov 28. doi: 10.3892/ijo.2017.4213.
    >> Share

  39. SONNENBLICK A, Salgado R, Brohee S, Zahavi T, et al
    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
    Int J Oncol. 2017 Nov 27. doi: 10.3892/ijo.2017.4212.
    >> Share

    J Biol Chem

  40. WANG D, Liu C, Wang J, Jia Y, et al
    Protein C receptor stimulates multiple signaling pathways in breast cancer cells.
    J Biol Chem. 2017 Dec 7. pii: M117.814046. doi: 10.1074/jbc.M117.814046.
    >> Share

    J Clin Invest

  41. MISHRA P, Tang W, Putluri V, Dorsey TH, et al
    ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.
    J Clin Invest. 2017 Nov 27. pii: 93815. doi: 10.1172/JCI93815.
    >> Share

    N Engl J Med

  42. MORCH LS, Skovlund CW, Hannaford PC, Iversen L, et al
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2017;377:2228-2239.
    >> Share

    Oral Contraceptives and the Small Increased Risk of Breast Cancer.
    N Engl J Med. 2017;377:2276-2277.
    >> Share

  44. DEMICHELE A, Yee D, Esserman L
    Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
    N Engl J Med. 2017;377:2287-2289.
    >> Share

    NPJ Breast Cancer

  45. HAYNES BP, Ginsburg O, Gao Q, Folkerd E, et al
    Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.
    NPJ Breast Cancer. 2017;3:47.
    >> Share

    Oncol Rep

  46. QIU N, He Y, Zhang S, Hu X, et al
    Cullin 7 is a predictor of poor prognosis in breast cancer patients and is involved in the proliferation and invasion of breast cancer cells by regulating the cell cycle and microtubule stability.
    Oncol Rep. 2017 Nov 21. doi: 10.3892/or.2017.6106.
    >> Share

    Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells.
    Oncol Rep. 2017 Nov 28. doi: 10.3892/or.2017.6116.
    >> Share

  48. SUI Y, Zhang X, Yang H, Wei W, et al
    MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Oncol Rep. 2017 Nov 27. doi: 10.3892/or.2017.6114.
    >> Share

  49. WANG Y, Li L, Wang H, Li J, et al
    Silencing TGIF suppresses migration, invasion and metastasis of MDAMB231 human breast cancer cells.
    Oncol Rep. 2017 Dec 4. doi: 10.3892/or.2017.6133.
    >> Share

  50. LIN SC, Chu PY, Liao WT, Wu MY, et al
    Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway.
    Oncol Rep. 2017 Nov 29. doi: 10.3892/or.2017.6123.
    >> Share

    PLoS One

  51. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    >> Share

  52. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    >> Share

  53. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    >> Share

  54. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    >> Share

  55. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    >> Share

  56. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    >> Share

  57. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016